Related Experiment Video
Updated: Apr 27, 2026
Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
Validity of cardiovascular risk prediction models in kidney transplant recipients
Holly Mansell1, Samuel Alan Stewart2, Ahmed Shoker3
1College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5.
Insights
Cardiovascular risk prediction models show limited validity in renal transplant recipients. The Framingham risk score underestimates events, and further validation is needed before clinical use.
Area of Science:
- Nephrology
- Cardiology
- Epidemiology
Background:
- Cardiovascular disease (CVD) is a primary cause of mortality in renal transplant recipients.
- Accurate prediction of cardiovascular risk is crucial for this patient population.
Purpose of the Study:
- To systematically review the validity of cardiovascular risk prediction models in renal transplant recipients.
- To assess the performance and limitations of existing models.
Main Methods:
- Systematic review of cohort studies with ≥1 year follow-up across five major databases.
- Extracted data on population characteristics, study design, and prognostic performance.
- Evaluated study bias using the Quality in Prognostic Studies (QUIPS) tool.
Main Results:
- Seven studies were included; five assessed the Framingham risk score, three used transplant-specific models.
- Model discrimination (c-statistic) ranged from 0.701 to 0.75 in four studies.
- Limited validation was found; only one model was internally and externally validated, and three studies had insufficient event rates.
Conclusions:
- Existing cardiovascular risk models, including the Framingham risk score, show underestimation and limited robustness in renal transplant recipients.
- While one model demonstrated external validation, comprehensive multi-cohort validation and impact analysis are recommended prior to widespread clinical adoption.
Background:
Predicting cardiovascular risk is of great interest in renal transplant recipients since cardiovascular disease is the leading cause of mortality.
Objective:
To conduct a systematic review to assess the validity of cardiovascular risk prediction models in this population.
Methods:
Five databases were searched (MEDLINE, EMBASE, SCOPUS, CINAHL, and Web of Science) and cohort studies with at least one year of follow-up were included. Variables that described population characteristics, study design, and prognostic performance were extracted. The Quality in Prognostic Studies (QUIPS) tool was used to evaluate bias.
Results:
Seven studies met the criteria for inclusion, of which, five investigated the Framingham risk score and three used a transplant-specific model. Sample sizes ranged from 344 to 23,575, and three studies lacked sufficient event rates to confidently reach conclusion. Four studies reported discrimination (as measured by c-statistic), which ranged from 0.701 to 0.75, while only one risk model was both internally and externally validated.
Conclusion:
The Framingham has underestimated cardiovascular events in renal transplant recipients, but these studies have not been robust. A risk prediction model has been externally validated at least on one occasion, but comprehensive validation in multiple cohorts and impact analysis are recommended before widespread clinical application is advocated.
Related Concept Videos
01:28Kidney Transplant I: Introduction
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:26Kidney Transplant II: Surgical Procedure
01:16Kidney Transplant III: Nursing Management
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...